Malignant pleural mesothelioma

We report a case of malignant pleural mesothelioma with histologically proven spontaneous regression of pleural disease. OBJECTIVES: Extrapleural pneumonectomy is a therapeutic option for selected patients with malignant pleural mesothelioma. Genome-wide array-based comparative genomic hybridization analysis of malignant pleural mesotheliomas (MPM) was carried out to identify regions that display DNA copy number alterations. As with malignant pleural mesothelioma, the diagnosis of malignant peritoneal mesothelioma is based on a pathologist%u2019s microscopic analysis of an individual%u2019s tissue. This type of mesothelioma is known as malignant pleural mesothelioma. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. The prognostic value of FDG-PET imaging in malignant pleural mesothelioma. Malignant pleural mesothelioma (MPM) is a rare form of cancer that originates in the pleura, the membrane which lines the chest cavity. This is the first reported case of malignant pleural mesothelioma to metastasize in such a manner. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. The management of malignant pleural mesothelioma; single centre experience in 10 years. Trimodality management of malignant pleural mesothelioma. Malignant pleural mesothelioma (MPM) moves through four stages, each one more serious than the next.